Evaluation and Management of Bilateral Hand and Foot Paresthesias in a 53-Year-Old Woman
This patient requires immediate screening for diabetes mellitus and vitamin B12 deficiency, followed by a focused neurologic examination to assess for peripheral neuropathy, as these are the most common treatable causes of symmetric distal paresthesias in this age group.
Initial Diagnostic Approach
The bilateral, symmetric distribution of tingling in both hands and feet strongly suggests a length-dependent peripheral neuropathy, where the longest nerves are affected first, producing the classic "stocking-glove" pattern 1. At age 53 with no other abnormalities, the priority is identifying reversible causes before considering idiopathic neuropathy (which accounts for 25-46% of cases) 1.
Essential Laboratory Testing
Order these tests immediately 1:
- Fasting blood glucose (diabetes is the most common identifiable cause)
- Vitamin B12 level (deficiency is readily treatable)
- Complete blood count (to assess for anemia or hematologic disorders)
- Comprehensive metabolic profile (kidney function, electrolytes)
- Thyroid-stimulating hormone (hypothyroidism can cause neuropathy)
- Serum protein electrophoresis with immunofixation (to exclude paraproteinemia)
Focused Clinical Examination
Perform a targeted neurologic assessment 2, 1:
- Test sensation with a 10-g monofilament on the dorsal aspect of both great toes, moving proximally until sensation is detected
- Check vibration sense using a 128-Hz tuning fork at the toes
- Assess ankle reflexes (often diminished or absent in peripheral neuropathy)
- Evaluate for weakness, particularly in distal muscles of hands and feet
- Examine for foot deformities (hammertoes, bunions, Charcot changes)
The inability to detect the 10-g monofilament indicates loss of protective sensation 3.
When to Consider Additional Testing
Electrodiagnostic studies (EMG/nerve conduction studies) are NOT routinely needed unless 2, 1:
- The clinical presentation is atypical or asymmetric
- There is significant motor weakness
- Entrapment syndromes (carpal tunnel, ulnar neuropathy) are suspected
- Initial laboratory workup is unrevealing
Note: Nerve conduction studies may be normal in small fiber neuropathy despite significant symptoms 4.
Management Based on Etiology
If Diabetes is Identified
Tight glycemic control is the only intervention proven to prevent progression 5, 6. Target HbA1c of 6-7% 2.
For symptomatic relief of neuropathic pain, numbness, and tingling 2, 5:
First-line pharmacologic options:
- Duloxetine 60-120 mg/day (FDA-approved; NNT 4.9-5.2 for 50% pain reduction; also treats depression) 2, 5
- Pregabalin 300-600 mg/day (FDA-approved; NNT 4.04-5.99; watch for dizziness, somnolence, peripheral edema, weight gain) 2, 5, 2
Second-line options if first-line fails:
- Gabapentin 900-3600 mg/day (doses in practice are often lower than trial doses) 2
- Tricyclic antidepressants (amitriptyline 10-75 mg/day starting low, especially in older patients; avoid if cardiac history or QTc prolongation) 2
Physical activity should be recommended for both neuropathy symptoms and overall diabetes management 7, 5.
If Vitamin B12 Deficiency is Found
Replace vitamin B12 appropriately based on severity and cause of deficiency 8, 1.
If Initial Workup is Negative
If all initial tests are normal and symptoms persist, refer to neurology for consideration of 1:
- Specific antibody assays
- Autonomic testing (if orthostasis, resting tachycardia present)
- Possible nerve biopsy in select cases
- Evaluation for rare causes (hereditary neuropathies, vasculitis, chronic inflammatory demyelinating polyneuropathy)
Critical Pitfalls to Avoid
Do not assume carpal tunnel syndrome just because hands are involved—bilateral symmetric hand AND foot involvement suggests generalized peripheral neuropathy, not entrapment 4, 9
Do not delay diabetes screening—even if the patient has no classic diabetes symptoms, peripheral neuropathy may be the presenting manifestation 2, 5
Do not order extensive testing upfront—the focused laboratory panel above identifies >75% of treatable causes 1
Do not overlook medication history—ask specifically about chemotherapy, alcohol use, and neurotoxic medications 8, 1
Asymmetric symptoms require different evaluation—if paresthesias are asymmetric, consider entrapment syndromes, radiculopathy, or other focal causes rather than generalized peripheral neuropathy 2
Symptomatic Management Regardless of Cause
Even while investigating etiology, address symptoms that affect quality of life:
- For neuropathic pain: Consider duloxetine or pregabalin as first-line agents 7, 5
- For sleep disturbance: Neuropathic pain characteristically worsens at night; treating pain improves sleep 2
- Foot care education: Daily foot inspection, proper footwear, moisturizers for dry skin, professional nail care 6